THE STATUS OF NEW IRON CHELATORS*
- 1 May 1980
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 344 (1) , 425-435
- https://doi.org/10.1111/j.1749-6632.1980.tb33682.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Chelation therapy in β-thalassemia major. I. Intravenous and subcutaneous deferoxamineThe Journal of Pediatrics, 1978
- Continuous Subcutaneous Administration of Deferoxamine in Patients with Iron OverloadNew England Journal of Medicine, 1977
- Iron chelation in cell cultures by two conjugates of 2, 3 - dihydroxybenzoic acid (2, 3 - DHB)Biochemical and Biophysical Research Communications, 1977
- Safety of Intensive Chelation TherapyNew England Journal of Medicine, 1977
- Hydroxamic acid polymers. II. Design of a polymeric chelating agent for ironJournal of Polymer Science: Polymer Chemistry Edition, 1976
- dl‐α‐TOCOPHEROL, IRON, AND LIPOFUSCIN IN THALASSEMIA*Annals of the New York Academy of Sciences, 1974
- The mechanism of iron uptake in Bacillus subtilisCanadian Journal of Microbiology, 1970
- Enterobactin, an iron transport compound from Salmonella typhimuriumBiochemical and Biophysical Research Communications, 1970
- Absorption of oral chelated ironBiochemical Medicine, 1970
- Products of “Low-iron Fermentation” with Bacillus subilis: Isolation, Characterization and Synthesis of 2,3-Dihydroxybenzoylglycine1,2Journal of the American Chemical Society, 1958